Introduction to Clearing the Smokescreen: the current evidence on cannabis use

Introduction to Clearing the Smokescreen: the current evidence on cannabis use

Bibliographic Details
Main Author:	Elizabeth Clare Temple
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-03-01
Series:	Frontiers in Psychiatry
Subjects:	Anxiety Cannabinoids Cannabis Schizophrenia Addiction dependence
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fpsyt.2015.00040/full

Similar Items

Cannabis associated mental health effects: A review
by: Neeraj Kancherla, et al.
Published: (2021-01-01)

Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users
by: Beata Ciesluk, et al.
Published: (2024-01-01)

Corrigendum: Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users
by: Beata Ciesluk, et al.
Published: (2024-02-01)

Cannabis-induced psychosis or Cannabis-associated psychosis: Diagnostically no clear winner
by: Srinivas Rajkumar, et al.
Published: (2016-01-01)

What You Need to Know About Cannabis: An Evidence-Based Crash Course for Mental Health Trainees
by: Thida Thant, et al.
Published: (2020-07-01)

Cannabis use and dependence among French schizophrenic inpatients
by: Michel eLejoyeux
Published: (2014-07-01)

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
by: Lara Sharpe, et al.
Published: (2020-10-01)

Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
by: Rumi Agarwal, et al.
Published: (2019-10-01)

Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users
by: Jasmine Turna, et al.
Published: (2020-10-01)

Cannabis use during adolescent development: susceptibility to psychiatric illness
by: Benjamin eChadwick, et al.
Published: (2013-10-01)

Cannabis and schizophrenia: characterisation of a risk factor in a sample of Moroccan patients hospitalised for psychosis
by: El Hassan Ouanouche, et al.
Published: (2022-02-01)

Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability
by: Ruth Braidwood, et al.
Published: (2018-03-01)

Assessing the adaptive role of cannabidiol (CBD) in Cannabis sativa defense against cannabis aphids
by: Jacob MacWilliams, et al.
Published: (2023-10-01)

The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
by: Koby Cohen, et al.
Published: (2018-02-01)

Cannabis Use and Anxiety: Is Stress the Missing Piece of the Puzzle?
by: Elizabeth Clare Temple, et al.
Published: (2014-11-01)

Cannabis, medical use and related policies reflections on society (tur)
by: Ebru Aldemir, et al.
Published: (2020-04-01)

Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
by: Cecilia Costiniuk, et al.
Published: (2023-07-01)

Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users
by: Koby Cohen, et al.
Published: (2020-05-01)

Chemical Characterization of 29 Industrial Hempseed (<i>Cannabis sativa</i> L.) Varieties
by: Sheyla Arango, et al.
Published: (2024-01-01)

Cannabis Pharmacogenomics: A Path to Personalized Medicine
by: Mariana Babayeva, et al.
Published: (2023-04-01)

Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications
by: M.M. Srinivas Bharath, et al.
Published: (2012-12-01)

Cannabis use and abuse correlates in a homogenous South African schizophrenia population
by: Liezl Koen, et al.
Published: (2009-03-01)

Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01)

Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom
by: Simon Erridge, et al.
Published: (2022-10-01)

Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence
by: Babasola O. Okusanya, et al.
Published: (2022-05-01)

Cannabis and risk of psychosis
by: M Drewe, et al.
Published: (2004-11-01)

Cannabinomics: Application of Metabolomics in Cannabis (Cannabis sativa L.) Research and Development
by: Konstantinos A. Aliferis, et al.
Published: (2020-05-01)

Aspectos terapêuticos de compostos da planta Cannabis sativa
by: Honório Káthia Maria, et al.
Published: (2006-01-01)

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
by: Zuardi A.W., et al.
Published: (2006-01-01)

Effects of Two Cannabidiol Oil Products on Self-Reported Stress Relief: A Quasi-Experimental Study
by: Mohammed Faraj, et al.
Published: (2023-11-01)

Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021–2022 survey
by: Zeeta Bawa, et al.
Published: (2022-12-01)

Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
by: Nadia Montero-Oleas, et al.
Published: (2020-01-01)

Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
by: Jan van Amsterdam, et al.
Published: (2018-09-01)

The Potential Use of Cannabis in Tissue Fibrosis
by: Nazar Pryimak, et al.
Published: (2021-10-01)

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
by: Zeinab Breijyeh, et al.
Published: (2021-02-01)

Cannabinoids for the treatment of cannabis abuse disorder
by: Andrés Rodríguez, et al.
Published: (2018-10-01)

The antimicrobial effect behind Cannabis sativa
by: Laureano Schofs, et al.
Published: (2021-04-01)

A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
by: Hebah Muhsien Sabiah AL Ubeed, et al.
Published: (2022-01-01)

Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population
by: Santiago Gómez Velásquez, et al.
Published: (2023-03-01)

Review of the Use of Medicinal Cannabis Products in Palliative Care
by: James Troyer, et al.
Published: (2024-04-01)